biote Corp.

Biote Corp. (Nasdaq: BTMD) is a hormone health company that became publicly traded following its business combination with Haymaker Acquisition Corp. III, a blank-check vehicle sponsored by Haymaker Group that completed its initial public offering in 2021 targeting the healthcare and wellness sector. The combined company operates in the practitioner-led hormone optimization space, focusing on subcutaneous pellet therapy alongside training and product distribution services for medical providers. As an established post-merger public company, biote filed a Form 8-K with the Securities and Exchange Commission on June 9, 2023. Investors and analysts seeking complete filing histories, deal timelines, and SPAC metrics for BTMD can sign up for full data access at SpacDesk.